Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care

Gerald F. Watts, Samuel S. Gidding, Pedro Mata, Jing Pang, David R. Sullivan, Shizuya Yamashita, Frederick J. Raal, Raul D. Santos, Kausik K. Ray

Research output: Contribution to journalArticle

Abstract

Optimal care for familial hypercholesterolaemia (FH) requires patient-centred management, multidisciplinary teamwork, involvement of primary care practitioners, patient networks, support groups and high-quality clinical registries, implemented through models of care adapted to FH. Models of care — evidence-based and context-specific frameworks that aim to deliver the highest quality of care for patients and their families — allow the application of precision and multidisciplinary medicine to FH care and can serve as paradigms for the prevention of premature atherosclerotic cardiovascular disease in all at-risk patients and families worldwide. The exponential growth in the number of publications on diverse aspects of FH has provided new knowledge for developing essential elements of existing models of care. These elements include clinical diagnostic criteria and genetic testing; risk restratification strategies; LDL-cholesterol treatment targets; management protocols for children; care of women in pregnancy; use of pharmacotherapies, including ezetimibe and PCSK9 inhibitors; use of lipoprotein apheresis for severe FH; and addressing barriers to care. However, substantial gaps remain that need to be addressed by a broad research agenda, implementation strategies and global collaboration and advocacy, aimed at improving the uptake, cost-effectiveness and routine implementation of evidence-based standards. In this Review, we summarize the dramatic increase in knowledge that informs adaptive models of care, with an emphasis on articles published since 2014.
Original languageEnglish
JournalNature Reviews Cardiology
DOIs
Publication statusPublished - 23 Jan 2020

Fingerprint

Hyperlipoproteinemia Type II
Precision Medicine
Blood Component Removal
Quality of Health Care
Self-Help Groups
Genetic Testing
LDL Cholesterol
Lipoproteins
Cost-Benefit Analysis
Registries
Publications
Primary Health Care
Cardiovascular Diseases
Drug Therapy
Pregnancy
Growth
Research

Cite this

Watts, Gerald F. ; Gidding, Samuel S. ; Mata, Pedro ; Pang, Jing ; Sullivan, David R. ; Yamashita, Shizuya ; Raal, Frederick J. ; Santos, Raul D. ; Ray, Kausik K. / Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care. In: Nature Reviews Cardiology. 2020.
@article{907f4176546049798f8ea805597fbd24,
title = "Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care",
abstract = "Optimal care for familial hypercholesterolaemia (FH) requires patient-centred management, multidisciplinary teamwork, involvement of primary care practitioners, patient networks, support groups and high-quality clinical registries, implemented through models of care adapted to FH. Models of care — evidence-based and context-specific frameworks that aim to deliver the highest quality of care for patients and their families — allow the application of precision and multidisciplinary medicine to FH care and can serve as paradigms for the prevention of premature atherosclerotic cardiovascular disease in all at-risk patients and families worldwide. The exponential growth in the number of publications on diverse aspects of FH has provided new knowledge for developing essential elements of existing models of care. These elements include clinical diagnostic criteria and genetic testing; risk restratification strategies; LDL-cholesterol treatment targets; management protocols for children; care of women in pregnancy; use of pharmacotherapies, including ezetimibe and PCSK9 inhibitors; use of lipoprotein apheresis for severe FH; and addressing barriers to care. However, substantial gaps remain that need to be addressed by a broad research agenda, implementation strategies and global collaboration and advocacy, aimed at improving the uptake, cost-effectiveness and routine implementation of evidence-based standards. In this Review, we summarize the dramatic increase in knowledge that informs adaptive models of care, with an emphasis on articles published since 2014.",
author = "Watts, {Gerald F.} and Gidding, {Samuel S.} and Pedro Mata and Jing Pang and Sullivan, {David R.} and Shizuya Yamashita and Raal, {Frederick J.} and Santos, {Raul D.} and Ray, {Kausik K.}",
year = "2020",
month = "1",
day = "23",
doi = "10.1038/s41569-019-0325-8",
language = "English",
journal = "Nature reviews. Cardiology",
issn = "1743-4297",
publisher = "Nature Publishing Group",

}

Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care. / Watts, Gerald F.; Gidding, Samuel S.; Mata, Pedro; Pang, Jing; Sullivan, David R.; Yamashita, Shizuya; Raal, Frederick J.; Santos, Raul D.; Ray, Kausik K.

In: Nature Reviews Cardiology, 23.01.2020.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care

AU - Watts, Gerald F.

AU - Gidding, Samuel S.

AU - Mata, Pedro

AU - Pang, Jing

AU - Sullivan, David R.

AU - Yamashita, Shizuya

AU - Raal, Frederick J.

AU - Santos, Raul D.

AU - Ray, Kausik K.

PY - 2020/1/23

Y1 - 2020/1/23

N2 - Optimal care for familial hypercholesterolaemia (FH) requires patient-centred management, multidisciplinary teamwork, involvement of primary care practitioners, patient networks, support groups and high-quality clinical registries, implemented through models of care adapted to FH. Models of care — evidence-based and context-specific frameworks that aim to deliver the highest quality of care for patients and their families — allow the application of precision and multidisciplinary medicine to FH care and can serve as paradigms for the prevention of premature atherosclerotic cardiovascular disease in all at-risk patients and families worldwide. The exponential growth in the number of publications on diverse aspects of FH has provided new knowledge for developing essential elements of existing models of care. These elements include clinical diagnostic criteria and genetic testing; risk restratification strategies; LDL-cholesterol treatment targets; management protocols for children; care of women in pregnancy; use of pharmacotherapies, including ezetimibe and PCSK9 inhibitors; use of lipoprotein apheresis for severe FH; and addressing barriers to care. However, substantial gaps remain that need to be addressed by a broad research agenda, implementation strategies and global collaboration and advocacy, aimed at improving the uptake, cost-effectiveness and routine implementation of evidence-based standards. In this Review, we summarize the dramatic increase in knowledge that informs adaptive models of care, with an emphasis on articles published since 2014.

AB - Optimal care for familial hypercholesterolaemia (FH) requires patient-centred management, multidisciplinary teamwork, involvement of primary care practitioners, patient networks, support groups and high-quality clinical registries, implemented through models of care adapted to FH. Models of care — evidence-based and context-specific frameworks that aim to deliver the highest quality of care for patients and their families — allow the application of precision and multidisciplinary medicine to FH care and can serve as paradigms for the prevention of premature atherosclerotic cardiovascular disease in all at-risk patients and families worldwide. The exponential growth in the number of publications on diverse aspects of FH has provided new knowledge for developing essential elements of existing models of care. These elements include clinical diagnostic criteria and genetic testing; risk restratification strategies; LDL-cholesterol treatment targets; management protocols for children; care of women in pregnancy; use of pharmacotherapies, including ezetimibe and PCSK9 inhibitors; use of lipoprotein apheresis for severe FH; and addressing barriers to care. However, substantial gaps remain that need to be addressed by a broad research agenda, implementation strategies and global collaboration and advocacy, aimed at improving the uptake, cost-effectiveness and routine implementation of evidence-based standards. In this Review, we summarize the dramatic increase in knowledge that informs adaptive models of care, with an emphasis on articles published since 2014.

U2 - 10.1038/s41569-019-0325-8

DO - 10.1038/s41569-019-0325-8

M3 - Article

JO - Nature reviews. Cardiology

JF - Nature reviews. Cardiology

SN - 1743-4297

ER -